Switzerland secures 14 million COVID-19 vaccines from Pfizer-BioNTech, Moderna for 2023
MT Newswires 2022
|
|
|
|
|
|
|
||||
Technical Analysis Trends PFIZER, INC.
In the short term | medium term | long term | |
tendencies | bearish | Neutral | Neutral |
Development of the income statement
Sell Buy |
|
Medium consensus | EXCEED |
Number of Analysts | 22 |
Last closing price |
$50.27 |
Average target price |
$57.68 |
Spread / Average Target | 14.7% |